July 2026
Largest Life Sciences Tools Public Companies in Australia
Benchmark revenue and EBITDA valuation multiples for public comps like
Vitrafy, AnteoTech, Microba Life Sciences, Proteomics and Pathkey.AI.
 | Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution to retain the quality of cryopreserved biomaterials. The company devices includes Vitrafy’s Smart Cryopreservation Device; Vitrafy’s Smart Thawing Device and Vitrafy’s Smart Packaging. | $2 | +83% | $161M | $145M | 3221.3x | (16.3x) | ||
| AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP. | $0 | +64% | $72M | $72M | 107.9x | (19.5x) | ||
| Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions. | $0 | -53% | $21M | $15M | 1.4x | (2.0x) | ||
| Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx. | $0 | -62% | $16M | $11M | 4.8x | (2.3x) | ||
| Pathkey.AI Ltd is engaged in the development of its digital tools that improve clinical trials, healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of the clinical research process. It invests in research and develops technologies as well as provides digital tools and insights services to healthcare, wellness, and science technology-focused clients. The group's main revenue streams are Retainer revenue and Project revenue. | $0 | -- | $14M | $14M | 751.5x | (15.3x) | ||
| Median | $0 | +5% | $21M | $15M | 107.9x | (15.3x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.